TAILIEUCHUNG - Treating Prostate Cancer: A Guide for Men With Localized Prostate Cancer

Breast cancer also elicits concerns regarding a woman’s view of herself. Many treat- ments for cancer challenge a woman’s body image and sexuality (Oktay, 1998). “The systemic treatment of breast cancer with chemotherapy or hormonal therapy may also affect self-image, fertility, and libido—all important components of ‘femininity’” (p. 6). The combined effects of breast surgery, loss of hair, decreased libido, and early meno- pause constitute a serious threat to a woman’s self-image. In addition, as the rate of breast cancer has increased in younger women, issues of femininity arising from the impact of disease on fertility are increasingly important (Oktay, 1998) | Effective Health Care Treating Prostate Cancer A Guide for Men With Localized Prostate Cancer Most men have time to learn about all the options for treating their prostate cancer. You have time to talk with your family and to discuss your options with your doctor or nurse. This guide can help you think about what is best for you now and in the future. . Agency for Healthcare Research and Quality Advancing Excellence in Health Care July 2008 WHAT DOES THIS GUIDE COVER This guide can help you work with your doctor to treat localized prostate cancer. The information comes from a government-funded review of research about treatments for localized prostate cancer. It covers research about four common prostate cancer treatments and their side effects. Watchful waiting carefully watching the cancer over time with regular checkups. Prostate surgery also called radical prostatectomy PRAHS-tah-TEK-toe-mee . Radiation one kind called external beam and another called brachytherapy BRAKE-ee-THAYR-uh-pee or seeding. Hormone treatment. WHAT IS NOT COVERED IN THIS GUIDE This guide does not cover how to prevent prostate cancer. It also does not talk about other treatments like ultrasound treatment cryotherapy freezing treatment laparoscopic surgery also called bandaid or keyhole surgery or robotic surgery. These are newer treatments. There isn t enough research yet to tell us how well they work compared with other treatments. This guide also does not cover herbal products like green tea or vitamins and minerals like selenium . It does not include treatments like chemotherapy for prostate cancer that has already spread outside the prostate gland. FAST FACTS About 9 out of 10 men with prostate cancer have cancer that has not spread outside the prostate gland. That means it is localized prostate cancer. Most men with localized prostate cancer survive their cancer. This is true with watchful waiting or any active treatment. Research can t tell us yet which option is best .

• Y học thường thức
• Subject Selection
• Relationship to Infertility
• Role of PDE5
• Obstructive
• Non Obstructive Azoosperm
• Gene Mutations
• BMC Musculoskeletal Disorders
• Selection bias
• Extension study
• Denosumab treatment
• Low fracture incidence
• Entire trial cohort
• Identification of mutations
• Exons 3 and 4 of the LDL Receptor gene
• LDL Receptor gene
• Familial hypercholesterolemia
• LDL Receptor gene in patients
• BMC Bioinformatics
• Catalog of somatic mutations in Cancer
• Somatic mutations
• Frameshift mutations
• Cancer genes
• Genome Biology
• Mutational processes
• Non coding cancer mutations
• Biological significance
• BMC Cancer
• Breast cancer
• Li Fraumeni
• Young women
• Heterozygous germline
• TP53 gene mutations
• Frequent tumor
• BRAF gene mutations
• Papillary thyroid carcinoma
• Langerhans cell histiocytosis
• Thyroid gland
• First decade
• Colorectal cancer
• Both germline
• APC gene
• Genetic mutations
• Chromosomal number
• Colon tumors
• Loss of genetic material
• KRAS gene
• Scientific reports
• scientific research
• biochemistry
• Mutations in the tumor suppressor breast cancer susceptibility gene 1 (BRCA1)
• an important player in the DNA damage response
• apoptosis
• cell cycle regulation and transcription
• confer a significantly elevated life time risk for breast and ovarian cancer
• Morquio A syndrome
• Missense mutations
• In silico analysis
• GALNS gene
• Genetic deficiency
• Chronological occurrence
• PI3KCA mutations
• PI3KCA gene mutational status
• Circulating tumor cells
• DNA sequencing technology
• Somatic point mutations
• Clustered gene filtering
• Support vector machine
• Sequential somatic mutations
• DNA damage response gene
• Tumor heterogeneity
• Tumor evolution
• Liver cancer
• Synonymous mutations
• Codon usage
• Gene expression
• Plant Biology
• Resistant starch
• Starch synthase
• Null mutations
• Health benefits
• Introduces insertions
• Splicing disruption
• Mutations generated
• CRISPR/Cas9 gene editing technology
• Premature termination codons
• Colorectal polyps
• KRAS mutation
• Digestive system
• KRAS gene mutations
• Endoscopic imaging characteristics
• Analysis of genes and genomes
• Basic techniques in gene analysis
• Cloning a gene
• Gene identification
• Creating mutations
• Polymerase chain reaction
• Acute myeloid leukemia
• Clinical samples
• HOX genes
• Poor survival
• Elevated HOX gene expression
• PARK 2 gene
• Parkin gene
• Breast carcinoma
• MDR salmonella
• 16S rRNA gene
• 23S rRNA gene
• RNA sequencing method
• Multidrug resistant salmonella serovars isolated
• Hepatocellular carcinoma
• Targeted sequencing
• Deleterious mutations
• Customized therapies
• Gene silencing
• Ki ras gene
• 3 methylcholanthrene
• Butylated hydroxytoluene
• Rat lung tissue
• Polycyclic aromatic hydrocarbon
• Waxy gene
• Amylose content
• DNA marker development
• Nucleotide Basic Local Alignment Search Tool
• Sanger method
• BMC Pediatrics
• POLR3 related leukodystrophy
• POLR3A gene
• Late childhood
• Progressive motor decline
• Alkaline phosphatase
• ALPL gene
• Tissue Non specific Alkaline Phosphatase
• Perinatal lethal
• Prenatal benign